Connecticut Innovations Invests $6 Million in Early-Stage Companies and Venture Funds in Q3 FY26
Connecticut Innovations (CI) invested $6.0 million in 15 companies and venture funds during Q3 FY26, leveraging an additional $295.3 million in outside capital. The investments included $3.0 million in healthcare and $2.5 million in technology sectors, with notable success from Veradermics' IPO, which raised $256 million. CI's disciplined approach to capital allocation was highlighted by its senior managing directors.
Topics: investment allocation IPO outside capital portfolio activity venture capital